Risk Management Expert, VP of Innovation@Caparna Inc
Verified
EXECUTIVE SUMMARY
Internationally recognized physician-executive and Chief Medical Officer with over 28 years of leadership across clinical research, pharmacovigilance, and global regulatory strategy. A strategic innovator with deep expertise in oncology, hematology, and immuno-oncology, guiding product development from IND through post-market across the US, EU, UK, LATAM, and APAC. Proven ability to shape clinical trial design, lead multidisciplinary teams, and scale enterprise-wide medical operations. Experienced board advisor and keynote speaker with strong networks in academic medicine, regulatory agencies, and pharma partnerships. Passionate about leveraging AI, real-world evidence, and data infrastructure to accelerate patient-centered outcomes and improve global health equity.
BOARD MEMBER PROFILE
Key Value Areas
- Clinical Relevance: Extensive background in global drug development, patient safety, and EHR optimization across high-impact therapeutic areas.
- Strategic Advisory: Advised multiple organizations on global launch readiness, regulatory filing strategy, and clinical trial governance.
- Network Development: Strong connections with CMIOs, KOLs, trial leaders, and innovation executives across oncology and academic medicine.
- Mission Advocacy: Frequent speaker at HLTH, DIA Europe, BIO-Europe, World Drug Safety EU, World Drug Safety Americas, and active contributor to innovation forums on AI in healthcare.
CORE COMPETENCIES
Clinical Trial Strategy & Oversight
Global Regulatory Affairs (FDA, EMA, MHRA, APAC, LATAM)
Pharmacovigilance & Risk Management
Health Data Infrastructure & AI Applications
Cross-Functional Team Leadership
Strategic Partnerships in Pharma/Academia
Medical Governance & Safety Science
Innovation Advocacy & Thought LeadershipMore...